Therapeutics

... oligos with endosomal escape moieties is bringing effective antisense techniques to rodent research. Such conjugates will likely debut soon as therapeutics. This is an open-access review of two delivery-enabled forms of Morpholinos. Moulton JD, Jiang S. Gene Knockdowns in Adult Animals: PPMOs ...

See entire post

... in the GH/IGF-1 Axis J.J. Kopchick, A. Bartke, and D.E. Berryman 14. Alzheimer’s Disease: Genetics, Pathogenesis, Models, and Experimental Therapeutics P.C. Wong, D.L. Price, L. Bertram, and R.E. Tanzi 15. How Does Calorie Restriction Increase the Longevity of Mammals? R. Weindruch, R.J. ...

See entire post

... collaborations between academia and the biotech industry have ultimately been beneficial to *patients* by accelerating development and delivery of therapeutics to the market places.

See entire post

... paralysis in Duchenne muscular dystrophy" This article give progress updates, quotes from scientists involved in developing exon-skipping therapeutics, and describes how exon skipping works. They discuss the regulatory problems of having many different sequences needed to treat many different ...

See entire post

... paralysis in Duchenne muscular dystrophy" This article give progress updates, quotes from scientists involved in developing exon-skipping therapeutics, and describes how exon skipping works. They discuss the regulatory problems of having many different sequences needed to treat many different ...

See entire post